Erlotinib OMNI379 Itraconazole (R51211) is a triazole

Itraconazole (R51211) is a triazole antifungal agent and a potent and orally active Hedgehog (Hh) signaling pathway antagonist with an IC50 of ~800 nM

likely mechanisms for semaglutide-induced weight loss include less appetite and food cravings

defined centrifugal force and predefined duration in every experiment

Erastin exhibits the mechanism of ferroptosis induction related to ROS and iron-dependent signaling

Erlotinib OMNI379 Itraconazole (R51211) is a triazoleErlotinib (CP 358774) is a directly acting EGFR tyrosine kinase inhibitor, with an IC50 of 2 nM for human EGFR. Erlotinib reduces EGFR autophosphorylation in intact tumor cells with an IC50 of 20 nM. Erlotinib is used for the treatment of non small cell lung cancer. Erlotinib is a click chemistry reagent, itcontains an Alkyne group and can undergo copper catalyzed azide alkyne cycloaddition (CuAAc) with molecules containing Azide groups.